CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Portugal

5 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Almada, Senhora Da Hora, Vila Nova de Gaia

  Age

  18 years and over

  People

  162 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07032662 · EU 2024-517614-14-00
• Phase 2/3Active, not recruiting
  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Almada, Braga, Porto

  Age

  18 years and over

  People

  201 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT05327114 · EU 2023-508425-28-00
• Phase 3Taking people
  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Where

  Porto

  Age

  18 years and over

  People

  218 worldwide

  Run by

  argenx

  See details and how to joinNCT06920004 · EU 2024-520097-36-00
• Phase 3Enrolling by invitation
  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Where

  Lisbon

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06859099 · EU 2024-517032-22-00
• Phase 3Taking people
  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Braga, Coimbra, Lisbon

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Sanofi

  See details and how to joinNCT06290141 · EU 2023-508338-33-00